For this reason, we predict that many more GLRA2 mutations remain to be discovered in a spectrum of neurological disorders encompassing ASD, DD, epilepsy and neuronal migration disorders and that detailed functional characterization will be required to distinguish different mutational pathomechanisms. This evidence concerns the gene GLRA2 and Abnormality of neuronal migration.